Table 1.
Group | Initial weight (g) | Final weight (g) | Thymus index (mg/g) | Spleen index (mg/g) |
---|---|---|---|---|
CG | 19.32 ± 0.39 | 25.48 ± 0.47 | 2.06 ± 0.20a | 2.55 ± 0.40b |
CTX | 19.47 ± 0.37 | 20.9 ± 0.60 | 1.50 ± 0.51c | 1.84 ± 0.21c |
PG | 19.05 ± 0.53 | 23.02 ± 1.30 | 2.01 ± 0.15a | 2.37 ± 0.39b |
LK | 19.23 ± 0.33 | 21.30 ± 0.48 | 1.87 ± 0.18ab | 1.95 ± 0.26c |
MK | 19.03 ± 0.55 | 22.33 ± 0.87 | 2.01 ± 0.21a | 3.12 ± 1.20a |
HK | 19.39 ± 0.38 | 23.02 ± 0.77 | 1.82 ± 0.17ab | 2.17 ± 0.30b |
Values are presented as means ± SD. Values in the same row with a different superscript differ significantly at p < .05.
Abbreviations: CG, control group; CTX, cyclophosphamide; HK, High ‐ KGM dose group with 400 mg; LK, Low ‐ KGM dose group with 200 mg; MK, Middle ‐ KGM dose group with 300 mg; PG, positive group.